{"database": "lobbying", "table": "lobbying_activities", "rows": [[2683947, "8ea90ca2-9432-4d22-b6b6-a6ca4bc75bdd", "Q3", "MEHLMAN CONSULTING, INC.", 284950, "BLUE SHIELD OF CALIFORNIA", 2021, "third_quarter", "PHA", "Prescription drug pricing.\nThe Build Back Better Act, A bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2021-10-18T09:48:00.907000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2683947"], "units": {}, "query_ms": 35.306161968037486, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}